Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Ronald Levy

1-50 of 57 results

View this query on the Wikidata Query Service
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma

scientific article published on September 15, 1997
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

scientific article published on October 1, 1997
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

scientific article published on October 15, 1994
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK

scientific article published on February 17, 2015
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer

scientific article published on 13 February 2012
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies

scientific article published on December 30, 2010
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

scientific article
The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile

scientific article published on 01 April 2002
A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies

scientific article published on December 1, 1979
Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection

scientific article published on October 1, 1992
Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

scientific article published on December 28, 1978
Eradication of spontaneous malignancy by local immunotherapy.

scientific article published in January 2018
BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma

scientific article published on May 8, 2003
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.

scientific article published on 29 April 2008
Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma

scientific article published on February 6, 2015
Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

scientific article
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

scientific article
Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone

scientific article published on August 15, 1998
Stereotactic Radiosurgery of Angiographically Occult Vascular Malformations: 14-Year Experience

scientific article published on August 1, 1998
Active and Passive Immunotherapy for Lymphoma: Proving Principles and Improving Results

scientific article published on April 11, 2011
Translational Medicine in Action: Anti-CD20 Therapy in Lymphoma

scientific article published on August 15, 2014
Pathological Changes in Surgically Resected Angiographically Occult Vascular Malformations after Radiation

scientific article published on April 1, 1998
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma

scientific article published on January 1, 2001
Therapy of lymphoma directed at idiotypes

scientific article published on January 1, 1990
Clinical relevance of immunologic phenotype in diffuse large cell lymphoma

scientific article published on 01 May 1984
Interleukin 3 is a growth factor for human follicular B cell lymphoma

scientific article published on February 1, 1992
Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody

scientific article published on September 1, 2012
Pan-Leukocyte Monoclonal Antibody L3B12: Characterization and Application to Research and Diagnostic Prob

scientific article published on 01 February 1984
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

scientific article published on 18 January 2019
The History of the Development of Vaccines for the Treatment of Lymphoma

scientific article published on September 1, 2000
Enhancement of antibody fragment secretion into the Escherichia coli periplasm by co-expression with the peptidyl prolyl isomerase, FkpA, in the cytoplasm

scientific article published on April 23, 2013
Immunomodulating antibodies and drugs for the treatment of hematological malignancies

scientific article published on March 1, 2011
Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells

scientific article published on September 15, 1992
New insights into the mechanism of action of immune checkpoint antibodies

scientific article published on August 3, 2014
TCR vaccines for active immunotherapy of T cell malignancies

scientific article published on December 1, 1997
A submicroscopic interstitial deletion of chromosome 14 frequently occurs adjacent to the t(14;18) translocation breakpoint in human follicular lymphoma

scientific article published on 01 March 1993
The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow

scientific article published on May 1, 2011
B-lymphoma cells are activated by peptide ligands of the antigen binding receptor or by anti-idiotypic antibody to induce extracellular acidification

scientific article published on December 1, 1995
Diversity of T-cell antigen receptor variable genes used by mycosis fungoides cells

scientific article published on January 1, 1992
Antigen selection in human lymphomagenesis

scientific article published on October 1, 1992
Transfer of specific immunity to B-cell lymphoma with syngeneic bone marrow in mice: a strategy for using autologous marrow as an anti-tumor therapy

scientific article published on November 15, 1991
Rationale for adjuvant idiotypic vaccination after high-dose therapy for multiple myeloma

scientific article published on August 1, 1997
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)
Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model

scientific article published on 01 January 1991
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

scientific article published on 01 September 2018
A brief personal history of cancer immunotherapy at Stanford: if these walls could talk…

scientific article published on May 1, 2014
Prolonged disease‐free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma

scientific article published on April 27, 2011
Tumor resistance induced by syngeneic bone marrow transplantation and enhanced by interleukin 2: a model for the graft versus leukemia reaction

scientific article published on August 1, 1992
Identification of Peptide Ligands for the Antigen Binding Receptor Expressed on Human B-Cell Lymphomas

scientific article published on January 1, 1998
Inhibition of lymphoma hybrids by human interferon

scientific article published on October 25, 1980

Paulina is supported by:

About Paulina

Help